PUR 0110 Rectal Enema ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	3

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01149707 (ClinicalTrials.gov)	June 1, 2010	22/6/2010	Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enemain Mild-to-Moderate Distal Ulcerative C ...	A 2-Week Exploratory Randomized, Double-Blind, Parallel-Group, Dose-Ranging, Placebo-Controlled Safe ...	Left-Sided Ulcerative Colitis;Proctosigmoiditis	Drug: PUR 0110 Rectal Enema250 mg;Drug: PUR 0110 Rectal Enema500 mg;Drug: PUR 0110 Rectal Enema1000 ...	PurGenesis Technologies Inc.	NULL	Completed	18 Years	75 Years	All	34	Phase 2	Germany
2	EUCTR2009-017839-18-DE (EUCTR)	14/05/2010	16/02/2010	A 2-WEEK EXPLORATORY RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, DOSE-RANGING, PLACEBO-CONTROLLED SAFE ...	A 2-WEEK EXPLORATORY RANDOMIZED, DOUBLE-BLIND, PARALLEL-GROUP, DOSE-RANGING, PLACEBO-CONTROLLED SAFE ...	Active mild-to-moderate distal ulcerative colitis MedDRA version: 13.1;Level: LLT;Classification cod ...	Product Name: PUR 0110 Product Code: PUR 0110 Other descriptive name: PCT (PureCell Technologies Compl ...	PurGenesis Techonologies Inc.	NULL	Not Recruiting			Female: yes Male: yes	56		Germany
3	NCT01149694 (ClinicalTrials.gov)	June 2009	22/6/2010	A Study to Assess the Safety and Tolerability of PUR 0110 Rectal Enema in Normal Healthy Volunteers	A Randomized, Double-Blind, Parallel-Group, Single-Ascending Dose, Placebo-Controlled Safety and Tol ...	Ulcerative Colitis	Drug: PUR 0110 Rectal Enema or Placebo Enema	PurGenesis Technologies Inc.	NULL	Completed	18 Years	55 Years	Male	24	Phase 1	Germany

First Previous1Next Last